Moreover, we showed that regulation of the Sirt1-PPARα-IGFBP-2 signaling cascade by AMPK activator represents a novel pathway that could be applied to ameliorate metabolic syndromes by controlling IGF-1 homeostasis. Here, PRKAA2 is linked to metabolic syndrome.